BackSonoma Pharmaceuticals Overview
Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Discounted Cash Flow

DCF Analysis for SNOA.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$-2.92

Current Fair Value

$-2.92
363.2% Downside

Overvalued by 363.2% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading